These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20557999)

  • 21. An investigation into the noradrenergic and serotonergic contributions of diffuse noxious inhibitory controls in a monoiodoacetate model of osteoarthritis.
    Lockwood SM; Bannister K; Dickenson AH
    J Neurophysiol; 2019 Jan; 121(1):96-104. PubMed ID: 30461363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noxious inhibition of temporal summation is impaired in chronic tension-type headache.
    Cathcart S; Winefield AH; Lushington K; Rolan P
    Headache; 2010 Mar; 50(3):403-12. PubMed ID: 19817882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse noxious inhibitory controls and brain networks are modulated in a testosterone-dependent manner in Sprague Dawley rats.
    Da Silva JT; Zhang Y; Asgar J; Ro JY; Seminowicz DA
    Behav Brain Res; 2018 Sep; 349():91-97. PubMed ID: 29733874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excitatory and inhibitory pain mechanisms during the menstrual cycle in healthy women.
    Tousignant-Laflamme Y; Marchand S
    Pain; 2009 Nov; 146(1-2):47-55. PubMed ID: 19592167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans.
    Pud D; Granovsky Y; Yarnitsky D
    Pain; 2009 Jul; 144(1-2):16-9. PubMed ID: 19359095
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffuse noxious inhibitory control. Reappraisal by pain-related somatosensory evoked potentials following CO2 laser stimulation.
    Kakigi R
    J Neurol Sci; 1994 Sep; 125(2):198-205. PubMed ID: 7807168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethnic differences in diffuse noxious inhibitory controls.
    Campbell CM; France CR; Robinson ME; Logan HL; Geffken GR; Fillingim RB
    J Pain; 2008 Aug; 9(8):759-66. PubMed ID: 18482870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse noxious inhibitory controls (DNIC) in animals and in man.
    Le Bars D; Villanueva L; Bouhassira D; Willer JC
    Patol Fiziol Eksp Ter; 1992; (4):55-65. PubMed ID: 1303506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pain sensitivity and descending inhibition of pain in Parkinson's disease.
    Mylius V; Engau I; Teepker M; Stiasny-Kolster K; Schepelmann K; Oertel WH; Lautenbacher S; Möller JC
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):24-8. PubMed ID: 18653553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables.
    Edwards RR; Ness TJ; Weigent DA; Fillingim RB
    Pain; 2003 Dec; 106(3):427-437. PubMed ID: 14659526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylephrine suppresses the pain modulation of diffuse noxious inhibitory control in rats.
    Makino K; Kohase H; Sanada T; Umino M
    Anesth Analg; 2010 Apr; 110(4):1215-21. PubMed ID: 20357157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans.
    Serrao M; Rossi P; Sandrini G; Parisi L; Amabile GA; Nappi G; Pierelli F
    Pain; 2004 Dec; 112(3):353-360. PubMed ID: 15561391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired diffuse noxious inhibitory controls in specific alternation of rhythm in temperature-stressed rats.
    Itomi Y; Tsukimi Y; Kawamura T
    Eur J Pharmacol; 2016 Aug; 784():61-8. PubMed ID: 27178898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications.
    Le Bars D; Dickenson AH; Besson JM
    Pain; 1979 Jun; 6(3):305-327. PubMed ID: 460936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal validity of inter-digital web pinching as a model for perceptual diffuse noxious inhibitory controls-induced hypoalgesia in healthy humans.
    Streff A; Michaux G; Anton F
    Eur J Pain; 2011 Jan; 15(1):45-52. PubMed ID: 20547464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK1 receptor-expressing spinoparabrachial neurons trigger diffuse noxious inhibitory controls through lateral parabrachial activation in the male rat.
    Lapirot O; Chebbi R; Monconduit L; Artola A; Dallel R; Luccarini P
    Pain; 2009 Apr; 142(3):245-254. PubMed ID: 19231081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic back pain, acute postoperative pain and the activation of diffuse noxious inhibitory controls (DNIC).
    Peters ML; Schmidt AJM; Van den Hout MA; Koopmans R; Sluijter ME
    Pain; 1992 Aug; 50(2):177-187. PubMed ID: 1408314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in pain perception and descending inhibitory controls start at middle age in healthy adults.
    Larivière M; Goffaux P; Marchand S; Julien N
    Clin J Pain; 2007; 23(6):506-10. PubMed ID: 17575490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An experimental model to measure excitatory and inhibitory pain mechanisms in humans.
    Tousignant-Laflamme Y; Pagé S; Goffaux P; Marchand S
    Brain Res; 2008 Sep; 1230():73-9. PubMed ID: 18652808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - new perspective of opioid-induced hyperalgesia.
    Ram KC; Eisenberg E; Haddad M; Pud D
    Pain; 2008 Oct; 139(2):431-438. PubMed ID: 18583047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.